(Q39146082)

9 September 2017

title

An armed oncolytic measles vaccine virus eliminates human hepatoma cells independently of apoptosis (English)

1 reference

9 September 2017

1 reference

1 reference

hepatocellular carcinoma

1 reference

1 reference

J Lampe

1

1 reference

9 September 2017

S Bossow

2

1 reference

9 September 2017

T Weiland

3

1 reference

9 September 2017

I Smirnow

4

1 reference

9 September 2017

R Lehmann

5

1 reference

9 September 2017

W Neubert

6

1 reference

9 September 2017

M Bitzer

7

1 reference

9 September 2017

U M Lauer

8

1 reference

9 September 2017

publication date

30 May 2013

1 reference

9 September 2017

1 reference

9 September 2017

volume

20

1 reference

9 September 2017

issue

11

1 reference

9 September 2017

page(s)

1033-1041

1 reference

Hepatocellular Carcinoma: Consensus Recommendations of the National Cancer Institute Clinical Trials Planning Meeting

9 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Gene therapy progress and prospects cancer: oncolytic viruses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Engineered measles virus as a novel oncolytic viral therapy system for hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Use of attenuated paramyxoviruses for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Phase I trial of intraperitoneal administration of an oncolytic measles virus strain engineered to express carcinoembryonic antigen for recurrent ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Reprogrammed viruses as cancer therapeutics: targeted, armed and shielded

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Lymphoma chemovirotherapy: CD20-targeted and convertase-armed measles virus can synergize with fludarabine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

An immunocompetent murine model for oncolysis with an armed and targeted measles virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Central and peripheral nervous system toxicity of common chemotherapeutic agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Bifunctional chimeric SuperCD suicide gene -YCD: YUPRT fusion is highly effective in a rat hepatoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Mechanism of interaction of thymidylate synthetase with 5-fluorodeoxyuridylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Chemovirotherapy for head and neck squamous cell carcinoma with EGFR-targeted and CD/UPRT-armed oncolytic measles virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Adenoviral vectors capable of replication improve the efficacy of HSVtk/GCV suicide gene therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Kaposi's sarcoma-associated herpesvirus viral IFN regulatory factor 1 inhibits transforming growth factor-beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Image-guided radiovirotherapy for multiple myeloma using a recombinant measles virus expressing the thyroidal sodium iodide symporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Combination of measles virus virotherapy and radiation therapy has synergistic activity in the treatment of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Heat shock protein inhibitors increase the efficacy of measles virotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

A measles virus vaccine strain derivative as a novel oncolytic agent against breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Effect of a caspase inhibitor, zVADfmk, on the inhibition of breast cancer cells by herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

New colorimetric cytotoxicity assay for anticancer-drug screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

Apoptosis as a cause of death in measles virus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

inferred from DOI database lookup

7 January 2021

based on heuristic

Non-invasive in vivo monitoring of trackable viruses expressing soluble marker peptides

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

inferred from DOI database lookup

7 January 2021

based on heuristic

1 reference

https://api.crossref.org/works/10.1038%2FGT.2013.28

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/GT.2013.28

1 reference

9 September 2017

1 reference